|
|
The benefits of using insulin glargine
Conclusins of an all-Canadian study (INSIGHT) demonstrate that adding insulin glargine
to type 2 diabetes therapy patients can safely achieve target blood sugar (glycemic) levels
faster and more frequently. Conclusions were announced June 13, 2005 at an international
diabetes congress.
Insulin glargine is approved for once-daily administration in patients over the age of
17 with type 1 or type 2 diabetes who require basal insulin to control abnormally high
blood sugar levels. Insulin glargine can be used with oral diabetes medications and/or
short-acting insulin to help control diabetes. During the study evaluation, patients using insulin
glargine expressed increased satisfaction with their treatment and experienced improved
The INSIGHT study (Implementing New Strategies with Insulin Glargine for Hyperglycemia
Therapy), is an all-Canadian study comparing the rate of people who reached
a target glycemic level (A1C) of 6.5 per cent or less, in two consecutive readings,
when insulin glargine was added to their current therapy, versus those on adjusted oral
therapy alone.
This study, involving 19 endocrinologists and 34 general practitioners, was
conducted at 53 study sites including British Columbia, Alberta, Manitoba, Ontario, Quebec,
Prince Edward Island, Nova Scotia and Newfoundland.
NOTE: The Information on this site is provided for information only,
and is not meant to substitute for the advice of your own physician or other medical professional.
<< back to diabetes
| |
Diabetes does not kill anybody, but "complications" do.
Would you like to know what you may do to turn your body “complications” free?
Just Click Here
SPONSORED LINKS
Your advertisement here
|
|
